Eli Lilly is spending up to $7.8 billion to buy Centessa, which is working on treatments for sleep-wake disorders. Eli Lilly has made yet another deal, this time buying a drug company that's ...

Eli Lilly has made yet another deal, this time buying a drug company that's developing a therapy for narcolepsy for up to $7.8 billion.

The latest international Harshita Varghese news and views from Reuters - one of the world's largest news agencies ...

The maker of popular GLP-1 drugs could soon be making and selling drugs discovered by AI.

Northwestern head women's basketball coach Carla Berube announced on Monday that Lilly Paro has been named Director of ...

Eli Roth’s The Horror Section and Mass Appeal, the entertainment company founded by Grammy-winning rapper Nas, have entered ...

Collaboration is elemental in the worlds of jazz and community service, and so it is quite natural for WBGO and JPI to ...

The FDA has some big verdicts lined up in the second quarter, including one for a closely watched obesity drug that many anticipate will further intensify competition in weight loss.

SEED Therapeutics, Inc. ("SEED"), a clinical-stage biotechnology company specializing in molecular glue degraders, today announced that it will have a poster presentation at the 2026 Annual Meeting of ...

Liam passed away in early March after a battle with leukemia. A percentage of the 'Dine and Donate' event's sales will be donated to Liam's family ...

VanEck Pharmaceutical ETF (NYSEARCA:PPH) exists to give investors broad exposure to the global pharmaceutical industry without the binary risk of betting on a single drug pipeline. Right now, that ...